Search Results - "Cassataro, Angela"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    HER3 (ERBB3) amplification in liposarcoma - a putative new therapeutic target? by Becker, Ann-Katharina, Puladi, Behrus, Xie, Kunpeng, Cassataro, Angela, Götzl, Rebekka, Hölzle, Frank, Beier, Justus P, Knüchel-Clarke, Ruth, Braunschweig, Till

    Published in World journal of surgical oncology (17-05-2024)
    “…Liposarcomas are among the most common mesenchymal malignancies. However, the therapeutic options are still very limited and so far, targeted therapies had not…”
    Get full text
    Journal Article
  2. 2

    Expression of programmed death ligand (PD-L1) in different tumors. Comparison of several current available antibody clones and antibody profiling by Kintsler, Svetlana, Cassataro, Maria Angela, Drosch, Michael, Holenya, Pavlo, Knuechel, Ruth, Braunschweig, Till

    Published in Annals of diagnostic pathology (01-08-2019)
    “…PD-L1 is a surface molecule which is expressed on different types of cells, including antigen presenting cells, vascular endothelial cells and other cells of…”
    Get full text
    Journal Article
  3. 3

    Evaluation of Therapeutic Targets in Histological Subtypes of Bladder Cancer by Wucherpfennig, Sophie, Rose, Michael, Maurer, Angela, Cassataro, Maria Angela, Seillier, Lancelot, Morsch, Ronja, Hammad, Ehab, Baldia, Philipp Heinrich, Ecke, Thorsten H, Vögeli, Thomas-Alexander, Knüchel, Ruth, Gaisa, Nadine T

    “…Histologically, bladder cancer is a heterogeneous group comprising urothelial carcinoma (UC), squamous cell carcinoma, adenocarcinomas (ACs), urachal…”
    Get full text
    Journal Article
  4. 4

    Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation by Morsch, Ronja, Rose, Michael, Maurer, Angela, Cassataro, Maria Angela, Braunschweig, Till, Knüchel, Ruth, Vögeli, Thomas-Alexander, Ecke, Thorsten, Eckstein, Markus, Weyerer, Veronika, Esposito, Irene, Ackermann, Maximilian, Niegisch, Günter, Gaisa, Nadine T

    Published in BMC cancer (18-03-2020)
    “…Immune checkpoint inhibitors (ICI) are an integral part of bladder cancer therapy, however, the relevance of ICI treatment for mixed and pure squamous cell…”
    Get full text
    Journal Article
  5. 5

    Development of a Rapid Analysis Method for Bone Resection Margins for Oral Squamous Cell Carcinoma by Immunoblotting by Haase, Claudia, Lethaus, Bernd, Knüchel-Clarke, Ruth, Hölzle, Frank, Cassataro, Angela, Braunschweig, Till

    Published in Head & neck pathology (Totowa, N.J.) (01-06-2018)
    “…The purpose of this proof-of-principle study was to develop a rapid and approachable method to analyse bone resection margins in patients with oral squamous…”
    Get full text
    Journal Article